Factors frequency (%) or median (range) unless otherwise stated | Cases | Controls | Univariate odds ratio | Multivariable odds ratio |
---|---|---|---|---|
N = 34 | N = 62 | (95% CI) [p value] | (95% CI) [p value]a | |
Central line present | 32 (97) | 60 (94) | 1.41 (0.19- 10.0) | - |
[0.73] | ||||
Central line duration (days) | 15.5 (2–37) | 14 (2–56) | [0.46] | - |
Not on enteral feeds | 8 (24%) | 4 (6%) | 4.28 (1.08-16.54) | - |
[0.04] | ||||
Duration intravenous lipid (days) | 16 (7–69) | 15 (1–35) | [0.09] | 1.25 (1.01-1.56) |
[0.0.049] | ||||
Duration intravenous amino acid (days) | 16 (3–70) | 16 (6–38) | 0.12 | - |
NEC preceding IC b | 12 (35) | 6 (10) | 7.04 (1.50-33.30) | 4.81 (1.14-20.41) |
[0.01] | [0.03] | |||
Bacterial infection including UTI | 17 (50) | 19 (31) | 2.26 (0.96-5.36) | 2.79 (0.57-13.68) |
[0.10] | [0.21] | |||
Any antifungal therapy prior to IC onset | 13 (35) | 10 (17) | 2.21 (0.71-6.85) | - |
[0.17] | ||||
Prior GI surgery | 2 (6) | 2 (3) | 2.59 (0.03-33.00) | - |
[0.43] | ||||
H 2 blocker | 9 (27) | 7 (11) | 2.94 (0.96-9.09) | 0.67 (0.13-3.46) |
[0.06] | [0.63] | |||
Steroids | 10 (29) | 13 (21) | 1.25 (0.34-4.57) | - |
[0.74] | ||||
Theophylline | 3 (9) | 3 (5) | 1.56 (0.24-10.56) | |
[0.64] | ||||
Intubation (median days) | 10 (1–71) | 9.5 (1–31) | 0.67 | - |
Broad spectrum antibiotics | 26 (76) | 37 (60) | 1.06 (0.97-1.15) | |
0.20 |